327 related articles for article (PubMed ID: 29313215)
1. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
2. Association of mitochondrial DNA content and displacement loop region sequence variations with cancer-related fatigue in breast cancer survivors receiving chemotherapy.
Toh YL; Wong E; Chae JW; Yap NY; Yeo AHL; Shwe M; Chan A
Mitochondrion; 2020 Sep; 54():65-71. PubMed ID: 32717446
[TBL] [Abstract][Full Text] [Related]
3. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
[TBL] [Abstract][Full Text] [Related]
4. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study.
Toh YL; Tan CJ; Yeo AHL; Shwe M; Ho HK; Gan YX; Foo KM; Chu P; Olson K; Chan A
J Cell Mol Med; 2019 Jun; 23(6):4281-4289. PubMed ID: 31016867
[TBL] [Abstract][Full Text] [Related]
6. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
7. Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy.
Weerts MJA; Hollestelle A; Sieuwerts AM; Foekens JA; Sleijfer S; Martens JWM
Clin Cancer Res; 2017 Aug; 23(16):4735-4743. PubMed ID: 28420722
[No Abstract] [Full Text] [Related]
8. Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer.
Cespedes Feliciano EM; Chen WY; Lee V; Albers KB; Prado CM; Alexeeff S; Xiao J; Shachar SS; Caan BJ
JAMA Oncol; 2020 Feb; 6(2):264-270. PubMed ID: 31804676
[TBL] [Abstract][Full Text] [Related]
9. Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer.
Shachar SS; Deal AM; Weinberg M; Williams GR; Nyrop KA; Popuri K; Choi SK; Muss HB
Clin Cancer Res; 2017 Jul; 23(14):3537-3543. PubMed ID: 28143874
[No Abstract] [Full Text] [Related]
10. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
12. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
[TBL] [Abstract][Full Text] [Related]
14. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
15. Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.
Oberste M; Schaffrath N; Schmidt K; Bloch W; Jäger E; Steindorf K; Hartig P; Joisten N; Zimmer P
BMC Cancer; 2018 Nov; 18(1):1071. PubMed ID: 30400840
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy.
Fumoleau P; Cortés-Funes H; Taleb AB; Chan S; Campone M; Pouget JC; Tubiana-Hulin M; Slabber CF; Caroff-Paraïso I; Alberts AS; Ben Ayed F
Am J Clin Oncol; 2009 Aug; 32(4):375-80. PubMed ID: 19487917
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
[TBL] [Abstract][Full Text] [Related]
18. [Management of anthracycline and taxane therapy-induced symptoms for the patients with breast cancer].
Fukada I; Ito Y
Nihon Rinsho; 2015 Feb; 73 Suppl 2():548-52. PubMed ID: 25831820
[No Abstract] [Full Text] [Related]
19. The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy.
Farr A; Stolz M; Baumann L; Bago-Horvath Z; Oppolzer E; Pfeiler G; Seifert M; Singer CF
Breast; 2017 Jun; 33():153-158. PubMed ID: 28395233
[TBL] [Abstract][Full Text] [Related]
20. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]